NCT03809611View on ClinicalTrials.gov

A Study of Safety and Efficacy of UNR844 Chloride (UNR844-Cl) Eye Drops in Subjects With Presbyopia.

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

April 26, 2019

Primary Completion Date

December 16, 2019

Study Completion Date

December 16, 2019

Conditions
Presbyopia
Interventions
DRUG

UNR844-Cl

1.5% Ophthalmic solution for topical ocular administration

DRUG

Placebo

placebo

Trial Locations (14)

16066

Novartis Investigative Site, Cranberry Township

17810

Novartis Investigative Site, Allenwood

18704

Novartis Investigative Site, Kingston

23502

Novartis Investigative Site, Norfolk

32757

Novartis Investigative Site, Mt. Dora

33773

Novartis Investigative Site, Largo

37205

Novartis Investigative Site, Nashville

38119

Novartis Investigative Site, Memphis

63090

Novartis Investigative Site, Washington

77204

Novartis Investigative Site, Houston

78613

Novartis Investigative Site, Cedar Park

91345

Novartis Investigative Site, Mission Hills

92663

Novartis Investigative Site, Newport Beach

37205-2013

Novartis Investigative Site, Nashville

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY